These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 3369446)

  • 21. Increased prevalence of chronic rhinosinusitis in carriers of a cystic fibrosis mutation.
    Wang X; Kim J; McWilliams R; Cutting GR
    Arch Otolaryngol Head Neck Surg; 2005 Mar; 131(3):237-40. PubMed ID: 15781764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular data on cystic fibrosis in Bulgaria.
    Kalaydjieva L; Antov J; Bronzova J; Vladimirova V; Horst J
    Hum Genet; 1990 Sep; 85(4):412-3. PubMed ID: 1976594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of cystic fibrosis mutations in the Grampian region of Scotland.
    Miedzybrodzka ZH; Dean JC; Russell G; Friend JA; Kelly KF; Haites NE
    J Med Genet; 1993 Apr; 30(4):316-7. PubMed ID: 8487279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Active intestinal chloride secretion in human carriers of cystic fibrosis mutations: an evaluation of the hypothesis that heterozygotes have subnormal active intestinal chloride secretion.
    Högenauer C; Santa Ana CA; Porter JL; Millard M; Gelfand A; Rosenblatt RL; Prestidge CB; Fordtran JS
    Am J Hum Genet; 2000 Dec; 67(6):1422-7. PubMed ID: 11055897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A method for analysing fertility of heterozygotes for autosomal recessive disorders, with special reference to cystic fibrosis, Tay-Sachs disease and phenylketonuria.
    Ten Kate LP
    Ann Hum Genet; 1977 Jan; 40(3):287-97. PubMed ID: 848858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Population-based genetic screening for cystic fibrosis: attitudes and outcomes.
    Ioannou L; Massie J; Collins V; McClaren B; Delatycki MB
    Public Health Genomics; 2010; 13(7-8):449-56. PubMed ID: 20090299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of cystic fibrosis mutations in Israeli Jews.
    Orgad S; Neumann S; Loewenthal R; Netanelov-Shapira I; Gazit E
    Genet Test; 2001; 5(1):47-52. PubMed ID: 11336401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative variation in cystic fibrosis-associated proteins in cystic fibrosis patients, carriers, and controls.
    Jamieson A; Mackinlay E; Aitken DA; Cooke A; Ferguson-Smith MA
    Hum Genet; 1985; 70(2):168-71. PubMed ID: 4007858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Difference in frequencies of the cystic fibrosis alleles, delta F508 and W1282X, between carriers and patients.
    Kalman YM; Kerem E; Darvasi A; DeMarchi J; Kerem B
    Eur J Hum Genet; 1994; 2(2):77-82. PubMed ID: 8044659
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Active cascade testing for carriers of cystic fibrosis gene.
    Super M; Schwarz MJ; Malone G; Roberts T; Haworth A; Dermody G
    BMJ; 1994 Jun; 308(6942):1462-7. PubMed ID: 8019278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cystic fibrosis mutation screening in healthy men with reduced sperm quality.
    van der Ven K; Messer L; van der Ven H; Jeyendran RS; Ober C
    Hum Reprod; 1996 Mar; 11(3):513-7. PubMed ID: 8671256
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cystic fibrosis heterozygotes do not have increased platelet activation.
    Tarnow I; Michelson AD; Frelinger AL; Linden MD; Li Y; Fox ML; Barnard MR; O'Sullivan BP
    Thromb Res; 2007; 121(2):159-62. PubMed ID: 17532368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Personal experiences of cystic fibrosis (CF) carrier couples prospectively identified in CF families.
    Henneman L; Kooij L; Bouman K; ten Kate LP
    Am J Med Genet; 2002 Jul; 110(4):324-31. PubMed ID: 12116205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cystic fibrosis in the South West African Afrikaner. An example of population drift, possibly with heterozygote advantage.
    Super M
    S Afr Med J; 1975 May; 49(20):818-20. PubMed ID: 1154135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Community-wide screening for cystic fibrosis carriers could replace newborn screening for the diagnosis of cystic fibrosis.
    Massie J; Forbes R; Dusart D; Bankier A; Delatycki MB
    J Paediatr Child Health; 2007 Nov; 43(11):721-3. PubMed ID: 17924936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. What young people think and do when the option for cystic fibrosis carrier testing is available.
    Mitchell J; Scriver CR; Clow CL; Kaplan F
    J Med Genet; 1993 Jul; 30(7):538-42. PubMed ID: 8411024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frequency of the hyperactive W493R ENaC variant in carriers of a CFTR mutation.
    Handschick M; Hedtfeld S; Tümmler B
    J Cyst Fibros; 2012 Jan; 11(1):53-5. PubMed ID: 21917531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A pilot survey of cystic fibrosis clinical manifestations in CFTR mutation heterozygotes.
    Castellani C; Quinzii C; Altieri S; Mastella G; Assael BM
    Genet Test; 2001; 5(3):249-54. PubMed ID: 11788092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Linkage relationships and allelic associations of the cystic fibrosis locus and four marker loci.
    Schmidtke J; Krawczak M; Schwartz M; Alkan M; Bonduelle M; Bühler E; Chemke M; Darnedde T; Domagk J; Engel W
    Hum Genet; 1987 Aug; 76(4):337-43. PubMed ID: 2886421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A stigmatizing effect of the carrier status for cystic fibrosis?
    Evers-Kiebooms G; Denayer L; Welkenhuysen M; Cassiman JJ; Van den Berghe H
    Clin Genet; 1994 Nov; 46(5):336-43. PubMed ID: 7889641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.